Back to Results
First PageMeta Content
Cancer organizations / Norwalk / Connecticut / Multiple Myeloma Research Foundation / Multiple Myeloma Research Consortium / Kathy Giusti / Bortezomib / Carfilzomib / Multiple myeloma / Onyx Pharmaceuticals / Medicine / Oncology / Cancer research


MULTIPLE MYELOMA RESEARCH FOUNDATION DONOR PROGRESS REPORTPOWERFUL THINKING ADVANCES THE CURE
Add to Reading List

Document Date: 2014-09-08 16:14:31

Open Document

File Size: 784,43 KB

Share Result on Facebook

Company

Johnson & Johnson / Takeda Oncology Company / Onyx Pharmaceuticals Inc. / Janssen Pharmaceuticals Inc. / Bristol-Myers Squibb / GenoSpace / /

Event

FDA Phase / Business Partnership / /

Facility

The University of Texas Science Center / Research Institute / The Medical College of Wisconsin / /

IndustryTerm

pharmaceutical / clinical network / web-based portal / /

MedicalCondition

multiple myeloma / disease / advanced multiple myeloma / incurable disease / community cancer / diseases / multiple myeloma patients / individualized cancer / /

Movie

Professor / /

Organization

Research Institute / Multiple Myeloma Research Foundation / U.S. Food and Drug Administration / H. Lee Moffitt Cancer Center / Medical College of Wisconsin / University of Texas Science Center / Dana-Farber Cancer Institute / U.S. Department of Veterans Affairs / /

Person

Mayo Clinic / Jana Jakubikova / Gateway / Edward Medina / Investigación del Cancer Indu Ramachandran / H. Lee Moffitt / John Quackenbush / Bryon Johnson / John Carpten / Ryan Holzer / Walter M. Capone / /

Position

Chief Operating Officer / CEO / independent evaluator / Researcher / Co-Founder and CEO / Professor and Director of IntegratedCancer Genomics Division / /

Product

Velcade / Zolinza / Kyprolis / Velcade® / Kyprolis® (carfilzomib) / /

ProvinceOrState

Wisconsin / /

Technology

Genomics / /

SocialTag